Home Industries Market Insights About Us Publisher Contact us

Targeted Therapeutics Market By Product Therapy (Monoclonal Antibodies, Small Molecule Inhibitors) By Cancer Type (Pancreatic cancer, Colorectal cancer, Lung cancer, Prostate cancer, Breast cancer, Melanoma, Others) Therapeutic Drugs Distribution Channel (Hospital Pharmacies, Online platforms, Retail pharmacies) By End User (Hospitals, Cancer treatment facilities, Others) - Global Opportunity Analysis And Industry Forecast, 2021-2027

Categories: Life Science

Formate :

Global Targeted Therapeutics Market Overview 

The Global Targeted Therapeutics market size is estimated to reach $74.3 billion by 2026, growing at a CAGR of 6.7% over the forecast period of 2021-2026. As its name suggests, Targeted therapeutics can be delineated as therapies taken into account in cancer treatment. Targeted cancer therapies are also restricted as molecularly targeted drugs/therapies. These therapies use precision drugs that identify and extinguish cancer cells in the body without affecting the regular cells. Most of the targeted therapies are dissimilar to standard practices like chemotherapy because they block the augmentation of tumors, whereas chemotherapies destroy cancer cells.

A few examples of targeted therapies are apoptosis inducers, Toxin delivery molecules, gene expression modulators, and immunotherapies. Besides, alemtuzumab, trastuzumab, and cetuximab are common drugs associated with targeted therapeutics. The targeted therapeutics market outlook is potentially captivating as the prevalence of cancer is elevating around the globe. Furthermore, enlarging approvals of targeted therapeutics from FDA, broadening research and developments activities are factors set to drive the growth of the Targeted Therapeutics Market for the period.

 

Impact of COVID-19:

COVID-19 harmed the market. Due to the limitations in movement and lockdowns, the targeted therapeutics market declined. Reduced visits to clinics and decreased or postponed diagnosis of cancer treatment, owing to the high priority of COVID-19 treatment in various healthcare facilities, affected the market. Also, logistic restrictions have affected the supply of components, drugs, and devices required for diagnosing cancer, thereby hindering market revenue growth.

 

Key Takeaways from Global Targeted Therapeutics Market Report:

  • Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units), and Value ($M) data given at country level – for Therapy, Cancer Type, Therapeutic Drugs, Distributional Channel, End-user, and by different industry verticals.

  • Understand the different market dynamics – key driving factors, challenges, and hidden opportunities.

  • Get in-depth insights on your competitor's performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.

  • Analyze the sales and distribution channels across key geographies to improve top-line revenues.

  • Understand the industry supply chain with a deep dive on the value augmentation at each step to optimize value and bring efficiencies in your processes. 

  • Get a quick outlook on the market entropy – M&As, deals, partnerships, product launches of all key players for the past four years. 

  • Evaluate the supply-demand gaps, import-export statistics, and regulatory landscape for more than the top 20 countries globally for the market. 

Targeted Therapeutics Market

By Cancer Type, the Lung and Prostate Cancer Segment market will grow at the highest CAGR during the forecast period.

During the forecast period, the lung and prostate cancer segments market is predicted to develop at the fastest rate of XX%. This growth is due to an increase in trends of smoking and drinking alcohol among adults and teenagers. On the other hand, worsening air quality due to accruing pollution also spikes the cases. The breast cancer segment held the largest share in 2020. The growth is owing to the massive prevalence of breast cancer cases in countries across the continents.

A study suggests that breast cancer is the most common type of tumor in the US and India. Breast cancer is more common among women than men because female breast cells are always visible to estrogen and progesterone growth hormones. More than 284,000 cases of breast cancer are found in the US. Besides proliferating old-age population, and obesity incidences are stimulating the risk of breast cancer prevalence.

 

By End-user, Hospital Segment to grow at the highest CAGR during the forecast period

The hospital segment is predicted to develop at the fastest CAGR during the projection period. The segment also held the largest share in the year 2020. It is owing to the broadening healthcare infrastructure in hospitals post COVID-19 as governments around the globe are assembling colossal packages to refine medical facilities. The hospital segment also held the largest share in 2020.

The growth is due to hospitals' far-reaching presence compared to other medical facilities. Additionally, hospitals offer several conveniences, such as 24/7 patient care, top-of-the-line medical professionals, the readiness of essential tools and techniques to perform several cancer procedures. Cancer treatment centers also provide top-notch treatment facilities to patients, but their lower presence and extortionate treatments turn many middle-class people apathetic toward them.

 

North America to account for the largest market share during the forecast period.

North America held the largest share of the Targeted Therapeutics market in 2020, with a global market share of 33%. The growth in this segment is due to factors such as the health-conscious public, besides world-class hospitals, research laboratories, and distribution channels network in developed countries like Canada, the US, etc. Moreover, affluent GDPs of these nations make a sure adequate amount of riches in research and development of novel drugs. On the other hand, the general public's high per capita income and living standards allow them to undergo available therapies and treatments. 

The Asia Pacific is set to be the fastest-growing over 2021-2026. This growth is due to accruing lung and prostate cancer cases due to the swelling geriatric population of Asian nations. Shooting up disposable income of people as economies of states like India, China, Indonesia, etc., are booming. Moreover, amplified expenditure on fine-tuning of healthcare facilities is also stimulating the growth in this segment.

 

Market Dynamics

Driver: 

Growing cancer prevalence and disposable income of people is Anticipated to Boost Product Demand.

The widespread prevalence of cancer is a major driver for the targeted therapeutics market. Ascribing to an upsurge in smoking, the number of people inflicted with it is augmenting. It's the main reason behind cancer deaths around the globe. In 2021 around 235,760 patients in the US will be identified with lung cancer. Moreover, over 130,000 deaths are reported every year in the US due to lung cancer.

Not just in the US, its spread has been augmented in other parts of the world as the smoking percentage of the world has reached around 19%. Besides, with sky-rocketing exports of many developing countries, their GDP per capita income is also elevating. With a 10% hike, Bangladesh's per capita income touched $2,227 in 2020-21. Therefore, with expansion in disposable income, people found themselves in much better positions regarding spending on healthcare.

 

 

Challenge:

Side effects allied with targeted therapies and drugs are Anticipated to Hamper Market Growth.

The targeted therapies and drugs linked with them have a wide range of applications in cancer treatment. Still, substantial health concerns are accompanied by such a procedure that is projected to strangle the respective market's growth. Some common hazards are hepatitis, diarrhea, liver complications such as enlargement in liver enzymes. On the other hand, depigmentation of hair, acneiform rash, reduced sperm production, and hypertension is other symptoms that patients can witness.

 

Key Market Players

Key Players in the Global Targeted Therapeutics Market consist of Pfizer, F. Hoffman -La Roche & Co., Aurinia Pharmaceutical, Nektar Therapeutics, Celdara medical, Arcus Biosciences, Genentech, Inc., AstraZeneca, Agenus, Inc., and Gilead sciences.

 

Recent Developments:

On July 21, 2021, the United Kingdom-based pharmaceutical giant AstraZeneca publicized that it had acquired US-based biopharmaceutical company "Alexion Pharmaceuticals." AstraZeneca closed the acquisition process by paying $39 billion to Alexion. The step will extend AstraZeneca an opportunity to expand its expertise in immunology and rare medications.

 

Report Coverage and Scope

The report “Global Targeted Therapeutics Market” by Research Informatic covers an in-depth detailed analysis for the following segment covered under the scope.

 

By Therapy

  • Monoclonal Antibodies

  • Small Molecule Inhibitors 

 

By Cancer Type

  • Pancreatic cancer

  • Colorectal cancer

  • Lung cancer

  • Prostate cancer

  • Breast cancer

  • Melanoma

  • Others

 

By Therapeutic Drugs Distribution Channel

  • Hospital Pharmacies

  • Online platforms

  • Retail pharmacies

 

By End-user

  • Hospitals

  • Cancer treatment facilities

  • Others

 

By Geography

  • North America

  • Europe

  • APAC

  • RoW

 

 


Chapter 1 Targeted Therapeutics Market Overview


1.1 Product Overview and Scope of Targeted Therapeutics


1.2 Targeted Therapeutics Market Segmentation By Therapy Type


1.2.1 Monoclonal Antibodies


1.2.2 Small Molecule Inhibitors


1.3 Targeted Therapeutics Market Segmentation By End User


1.3.1 Hospitals


1.3.2 Cancer treatment facilities


1.3.3 Others


1.4 Targeted Therapeutics Market Segmentation by Regions


1.4.1 North America


1.4.2 China


1.4.3 Europe


1.4.4 Southeast Asia


1.4.5 Japan


1.4.6 India


1.5 Global Market Size (Value) of Targeted Therapeutics (2015-2027)


 


Chapter 2 Global Economic Impact on Targeted Therapeutics Industry


2.1 Global Macroeconomic Environment Analysis


2.1.1 Global Macroeconomic Analysis


2.1.2 Global Macroeconomic Environment Development Trend


2.2 Global Macroeconomic Environment Analysis by Regions


 


Chapter 3 Global Targeted Therapeutics Market Competition by Manufacturers


3.1 Global Targeted Therapeutics Production and Share by Manufacturers (2021 and 2021)


3.2 Global Targeted Therapeutics Revenue and Share by Manufacturers (2021 and 2021)


3.3 Global Targeted Therapeutics Average Price by Manufacturers (2021 and 2021)


3.4 Manufacturers Targeted Therapeutics Manufacturing Base Distribution, Production Area and Product Type


3.5 Targeted Therapeutics Market Competitive Situation and Trends


3.5.1 Targeted Therapeutics Market Concentration Rate


3.5.2 Targeted Therapeutics Market Share of Top 3 and Top 5 Manufacturers


3.5.3 Mergers & Acquisitions, Expansion


 


Chapter 4 Global Targeted Therapeutics Production, Revenue (Value) by Region (2015-2021)


4.1 Global Targeted Therapeutics Production by Region (2015-2021)


4.2 Global Targeted Therapeutics Production Market Share by Region (2015-2021)


4.3 Global Targeted Therapeutics Revenue (Value) and Market Share by Region (2015-2021)


4.4 Global Targeted Therapeutics Production, Revenue, Price and Gross Margin (2015-2021)


4.5 North America Targeted Therapeutics Production, Revenue, Price and Gross Margin (2015-2021)


4.6 Europe Targeted Therapeutics Production, Revenue, Price and Gross Margin (2015-2021)


4.7 China Targeted Therapeutics Production, Revenue, Price and Gross Margin (2015-2021)


4.8 Japan Targeted Therapeutics Production, Revenue, Price and Gross Margin (2015-2021)


4.9 Southeast Asia Targeted Therapeutics Production, Revenue, Price and Gross Margin (2015-2021)


4.10 India Targeted Therapeutics Production, Revenue, Price and Gross Margin (2015-2021)


 


Chapter 5 Global Targeted Therapeutics Supply (Production), Consumption, Export, Import by Regions (2015-2021)


5.1 Global Targeted Therapeutics Consumption by Regions (2015-2021)


5.2 North America Targeted Therapeutics Production, Consumption, Export, Import by Regions (2015-2021)


5.3 Europe Targeted Therapeutics Production, Consumption, Export, Import by Regions (2015-2021)


5.4 China Targeted Therapeutics Production, Consumption, Export, Import by Regions (2015-2021)


5.5 Japan Targeted Therapeutics Production, Consumption, Export, Import by Regions (2015-2021)


5.6 Southeast Asia Targeted Therapeutics Production, Consumption, Export, Import by Regions (2015-2021)


5.7 India Targeted Therapeutics Production, Consumption, Export, Import by Regions (2015-2021)


 


Chapter 6 Global Targeted Therapeutics Production, Revenue (Value), Price Trend by Type


6.1 Global Targeted Therapeutics Production and Market Share by Type (2015-2021)


6.2 Global Targeted Therapeutics Revenue and Market Share by Type (2015-2021)


6.3 Global Targeted Therapeutics Price by Type (2015-2021)


6.4 Global Targeted Therapeutics Production Growth by Type (2015-2021)


 


Chapter 7 Global Targeted Therapeutics Market Analysis by Application


7.1 Global Targeted Therapeutics Consumption and Market Share by Application (2015-2021)


7.2 Global Targeted Therapeutics Consumption Growth Rate by Application (2015-2021)


7.3 Market Drivers and Opportunities


7.3.1 Potential Applications


7.3.2 Emerging Markets/Countries


 


Chapter 8 Targeted Therapeutics Manufacturing Cost Analysis


8.1 Targeted Therapeutics Key Raw Materials Analysis


8.1.1 Key Raw Materials


8.1.2 Price Trend of Key Raw Materials


8.1.3 Key Suppliers of Raw Materials


8.1.4 Market Concentration Rate of Raw Materials


8.2 Proportion of Manufacturing Cost Structure


8.2.1 Raw Materials


8.2.2 Labour Cost


8.2.3 Manufacturing Expenses


8.3 Manufacturing Process Analysis of Nano Diamond Battery


 


Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers


9.1 Targeted Therapeutics Industrial Chain Analysis


9.2 Upstream Raw Materials Sourcing


9.3 Raw Materials Sources of Targeted Therapeutics Major Manufacturers in 2021


9.4 Downstream Buyers


 


Chapter 10 Marketing Strategy Analysis, Distributors/Traders


10.1 Marketing Channel


10.1.1 Direct Marketing


10.1.2 Indirect Marketing


10.1.3 Marketing Channel Development Trend


10.2 Market Positioning


10.2.1 Pricing Strategy


10.2.2 Brand Strategy


10.2.3 Target Client


10.3 Distributors/Traders List


 


Chapter 11 Market Effect Factors Analysis


11.1 Technology Progress/Risk


11.1.1 Substitutes Threat


11.1.2 Technology Progress in Related Industry


11.2 Consumer Needs/Customer Preference Change


11.3 Economic/Political Environmental Change


 


Chapter 12 Global Targeted Therapeutics Market Forecast (2021-2027)


12.1 Global Targeted Therapeutics Production, Revenue Forecast (2021-2027)


12.2 Global Targeted Therapeutics Production, Consumption Forecast by Regions (2021-2027)


12.3 Global Targeted Therapeutics Production Forecast by Type (2021-2027)


12.4 Global Targeted Therapeutics Consumption Forecast by Application (2021-2027)


12.5 Targeted Therapeutics Price Forecast (2021-2027)


 


Chapter 13 Appendix    


 


 


 

Request For Methodology

To receive a sample copy of this report, please complete the form below

Kindly share your specific requirement (if any)

Request For List Of Tables

To receive a sample copy of this report, please complete the form below

Kindly share your specific requirement (if any)

FAQ

What is Targeted Therapeutics?

Targeted therapeutics can be delineated as therapies taken into account in cancer treatment. Targeted cancer therapies are also restricted as molecularly targeted drugs/therapies. These therapies use precision drugs that identify and extinguish cancer cells in the body without affecting the regular cells.

What is the Targeted Therapeutics market share?

The Global Targeted Therapeutics market size is estimated to reach $74.3 billion by 2026, growing at a CAGR of 6.7% over the forecast period of 2021-2026.

What are the key factors driving the Targeted Therapeutics Market?

The widespread prevalence of cancer is a major driver for the targeted therapeutics market. Ascribing to an upsurge in smoking, the number of people inflicted with it is augmenting.

What are the top companies in the Targeted Therapeutics Market?

Pfizer, F. Hoffman -La Roche & Co., Aurinia Pharmaceutical, Nektar Therapeutics, Celdara medical, Arcus Biosciences, Genentech, Inc., AstraZeneca, Agenus, Inc., and Gilead sciences.

Which region has largest share in Global Targeted Therapeutics Market?

North America held the largest share of the Targeted Therapeutics market in 2020, with a global market share of 33%.

What is Targeted Therapeutics?

As its name suggests, Targeted therapeutics can be delineated as therapies taken into account in cancer treatment. Targeted cancer therapies are also restricted as molecularly targeted drugs/therapies. These therapies use precision drugs that identify and extinguish cancer cells in the body without affecting the regular cells.

Choose License Type

Single User

US$ 3500

Multi User

US$ 5250

Corporate User

US$ 7000

Personalize this Research

  • Market Size and Share from 2016 - 2027
  • Expected Market Growth Until 2027
  • COVID-19 Impact assessment on the market
  • Market Dynamics and Impact Analysis
  • Segment and region that will drive or lead the market growth and why
  • Industry activity comprising Mergers, Acquisitions, Expansion, etc.
  • Comprehensive Mapping of the Competitive Landscape
  • In-depth analysis of key sustainability strategies adopted by market players
  • Global and regional market trends – Current and Future
  • Value Chain Analysis
  • Porters Five Forces Analysis
  • Historical and Current Product Pricing
  • Country Cross-Segment Analysis
  • Company Profiling
  • Player Comparison Matrix

Life Science Clients

Targeted Therapeutics Market By Product Therapy (M...

RD Code : HP22